FG
IDXX icon

Fairman Group’s Idexx Laboratories IDXX Stock Holding History

Fairman Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$1.52K – 372
2024
Q3 		$1.52K Hold
3
– – ﹤0.01% 300
2024
Q2 		$1.46K Hold
3
– – ﹤0.01% 297
2024
Q1 		$1.62K Hold
3
– – ﹤0.01% 290
2023
Q4 		$1.67K Buy
+3
New +$1.41K ﹤0.01% 282

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fairman Group's IDXX Position: Q4 2024 in Review

Fairman Group sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 3 shares — an estimated $1.52K sold.

Fairman Group first reported a position in IDXX in Q4 2023 and held it in 4 quarters. The position peaked at $1.67K in Q4 2023. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Fairman Group reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Fairman Group sold 3 Idexx Laboratories shares in Q4 2024, an estimated $1.52K.
  • Fairman Group first reported a position in Idexx Laboratories in Q4 2023 and held it in 4 quarters.
  • Fairman Group's Idexx Laboratories position peaked at $1.67K in Q4 2023.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Fairman Group's 13F filing for Q4 2024, filed 29 Jan 2025.